⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 2, 2024Open Access

Supplementary Figure 10 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models

Fabian F. Pusch Heathcliff Dorado García Robin Xu Dennis Gürgen Yi Bei Lotte Brückner Claudia Röefzaad Jennifer von Stebut Victor Bardinet Rocío Chamorro González Angelika Eggert Johannes H. Schulte Patrick Hundsdörfer Georg Seifert Kerstin Haase Beat W. Schäfer Marco Wachtel Anja A. Kühl Michael V. Ortiz Antje M. Wengner Monika Scheer Anton G. Henssen

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Supplementary Figure 10 shows the IHC markers tested in MNA and NMNA NB PDXs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pusch et al. (2024) studied this question.

synapsesocial.com/papers/68e70c5ab6db6435876860ee https://doi.org/10.1158/1535-7163.25523229

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 10 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models2024
2Supplementary Figure 11 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models2024
3Supplementary Figure 11 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models2024
4Supplementary Figure 9 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models2024
5Supplementary Figure 9 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models2024

More related papers

Supplementary Figure 8 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models2024
Supplementary Figure 8 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models2024
Supplementary Figure 5 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models2024